1. Hull, R., et al., Cervical cancer in low and middle‑income countries. Oncology Letters, 2020. 20(3): p. 2058–2074.
2. Waggoner, S., Cervical cancer. The Lancet, 2003. 361(9376): p. Pages 2217–2225.
3. Goodman, A., HPV testing as a screen for cervical cancer. Bmj, 2015. 350.
4. Oyervides-Muñoz, M.A., et al., Understanding the HPV integration and its progression to cervical cancer. Infection, Genetics and Evolution, 2018. 61: p. 134–144.
5. Morgan, E.L., et al., E6-Mediated activation of JNK drives EGFR signalling to promote proliferation and viral oncoprotein expression in cervical cancer. Cell Death & Differentiation, 2020: p. 1–19.
6. Doorbar, J., Molecular biology of human papillomavirus infection and cervical cancer. Clinical science, 2006. 110(5): p. 525–541.
7. Yim, E.-K. and J.-S. Park, The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer research and treatment: official journal of Korean Cancer Association, 2005. 37(6): p. 319.
8. Hickman, E.S., M.C. Moroni, and K. Helin, The role of p53 and pRB in apoptosis and cancer. Current opinion in genetics & development, 2002. 12(1): p. 60–66.
9. Münger, K., et al., Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene, 2001. 20(54): p. 7888–7898.
10. Mantovani, F. and L. Banks, The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene, 2001. 20(54): p. 7874–7887.
11. Mortazavi Farsani, S., et al., The effects of Nanocurcumin on Expression Induction of Transcription Factors Involved in Hematopoietic Stem Cell Differentiation to Precursor Myeloid Cells. Modares Journal of Biotechnology, 2019. 10(4): p. 601–608.
12. Farsani, S.S.M., et al., Nanocurcumin as a novel stimulator of megakaryopoiesis that ameliorates chemotherapy-induced thrombocytopenia in mice. Life Sciences, 2020: p. 117840.
13. Anand, P., et al., Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer letters, 2008. 267(1): p. 133–164.
14. Prusty, B.K. and B.C. Das, Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP‐1 activity in HeLa cells by curcumin. International journal of cancer, 2005. 113(6): p. 951–960.
15. Zaman, M.S., et al., Curcumin nanoformulation for cervical cancer treatment. Scientific reports, 2016. 6: p. 20051.
16. TAHMASEBI, B.M., et al., Dendrosomal Nano-curcumin, the Novel Formulation to Improve the Anticancer Properties of Curcumin. 2015.
17. Babaei, E., et al., Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo. International immunopharmacology, 2012. 12(1): p. 226–234.
18. Syng-ai, C., A.L. Kumari, and A. Khar, Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Molecular cancer therapeutics, 2004. 3(9): p. 1101–1108.
19. Kumar, P., A. Nagarajan, and P.D. Uchil, Analysis of cell viability by the MTT assay. Cold Spring Harbor Protocols, 2018. 2018(6): p. pdb. prot095505.
20. Masters, J.R., HeLa cells 50 years on: the good, the bad and the ugly. Nature Reviews Cancer, 2002. 2(4): p. 315–319.
21. Diao, M.-K., et al., Integrated HPV genomes tend to integrate in gene desert areas in the CaSki, HeLa, and SiHa cervical cancer cell lines. Life sciences, 2015. 127: p. 46–52.
22. Duvoix, A., et al., Chemopreventive and therapeutic effects of curcumin. Cancer letters, 2005. 223(2): p. 181–190.
23. Anand, P., et al., Bioavailability of curcumin: problems and promises. Molecular pharmaceutics, 2007. 4(6): p. 807–818.
24. Prasad, S., A.K. Tyagi, and B.B. Aggarwal, Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer research and treatment: official journal of Korean Cancer Association, 2014. 46(1): p. 2.
25. Alizadeh, A.M., et al., Chemoprevention of azoxymethane-initiated colon cancer in rat by using a novel polymeric nanocarrier–curcumin. European journal of pharmacology, 2012. 689(1–3): p. 226–232.
26. Montazeri, M., et al., Dendrosomal curcumin nanoformulation modulate apoptosis-related genes and protein expression in hepatocarcinoma cell lines. International journal of pharmaceutics, 2016. 509(1–2): p. 244–254.
27. Sadeghzadeh, H., et al., The effects of nanoencapsulated curcumin-Fe3O4 on proliferation and hTERT gene expression in lung cancer cells. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents), 2017. 17(10): p. 1363–1373.
28. Sordillo, P.P. and L. Helson, Curcumin and cancer stem cells: curcumin has asymmetrical effects on cancer and normal stem cells. Anticancer Research, 2015. 35(2): p. 599–614.
29. Javidi, M.A., et al., Investigating curcumin potential for diabetes cell therapy, in vitro and in vivo study. Life sciences, 2019. 239: p. 116908.
30. Zur Hausen, H., Papillomaviruses and cancer: from basic studies to clinical application. Nature reviews cancer, 2002. 2(5): p. 342–350.
31. Flowers, L.C., et al., Curcumin suppresses growth of cervical cancer cells. 2005, AACR.
32. Mishra, A. and B.C. Das, Curcumin as an anti-human papillomavirus and anti-cancer compound. Future Oncology, 2015. 11(18): p. 2487–2490.
33. Dang, Y.-P., et al., Curcumin improves the paclitaxel‑induced apoptosis of HPV‑positive human cervical cancer cells via the NF‑κB‑p53‑caspase‑3 pathway. Experimental and therapeutic medicine, 2015. 9(4): p. 1470–1476.
34. Ravindran, J., S. Prasad, and B.B. Aggarwal, Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? The AAPS journal, 2009. 11(3): p. 495–510.